ISMPP Highlights
Add a Graduate Degree to Your Resume (and Keep Working Full-Time) ̶ Check Out this ISMPP Member Benefit
As a demonstration of ISMPP’s commitment to preparing the profession to meet (and exceed) the demands in the market, we are pleased to remind all ISMPP members and employees about the educational partnership with the University of Florida College of Pharmacy’s online graduate program in Pharmaceutical Outcomes and Policy…
ISMPP Releases Official Guidance to Address Authorship Challenges Related to COVID-19 Outbreak
Author responsiveness concerns in the wake of the coronavirus disease (COVID-19) global pandemic has resulted in apprehension and numerous inquiries from ISMPP members over the past several weeks. To address these unprecedented circumstances, ISMPP convened a consensus panel of experts to develop an Official Guidance…
Predatory Publishing Joint Position Statement Now in Multiple Languages
AMWA, EMWA, and ISMPP released their Joint Position Statement on Predatory Publishing in July 2019, published in Current Medical Research & Opinion (CMRO). The organizations are pleased to announce that six months after publication, the Joint Position Statement is available in eight languages…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
How Article-Level Metrics Can Improve Your Publication Planning
Effective publication planning requires a good understanding of the uptake and impact of individual publications. In the past, our ability to measure this has been limited because publication planners have only had access to journal impact factors and citation counts. With the advent of web-native and article-level metrics…
Advisory Boards: Words of Advice and a 10-point Checklist
Are you considering running an advisory board meeting? Do you want to improve on an advisory board you managed recently – or are you about to start planning your first? Do you have questions such as: How do I plan the meeting? How can I ensure compliance with regulations? Whom should I invite? How can I ensure the meeting meets my objectives?…
What Is Health Literacy in Clinical Research Communications, and Why Is It Important?
Communicating with patients about clinical trials is challenging in today’s increasingly complex world of treatment options. While access to information about clinical trials is more widely available, patients with serious illnesses can be easily overwhelmed before they fully understand their options. This gap between access and understanding…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: The Authorship Order Dilemma
You are a company medical publication professional. The publication steering committee of a company-sponsored pivotal phase 3 clinical trial has selected investigators to serve as authors, but the committee and authors are having difficulty in deciding the order of authorship. During discussions, multiple authors believe that they have equal rights to the first author position based on their contributions. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals